-
Dr. Jill O’Donnell-Tormey Discusses the Latest Developments in Immunological Technologies
CRI’s CEO and Director of Scientific Affairs, Dr. Jill O’Donnell-Tormey, recently spoke with ecancer about recent developments… -
CRI’s Wear White Luncheon Raises Over $30,000
By Rebecca Jensen The Cancer Research Institute held its fourth annual Wear White Luncheon, hosted by Mary… -
Skin Cancer Awareness Month: 2022 Immunotherapy Research Updates
This Skin Cancer Awareness month, discover new research, treatments, and progress for a future immune to skin…
-
Bladder Cancer Awareness Month: 2022 Immunotherapy Research Updates
This Bladder Cancer Awareness Month, discover new research, new treatments, and progress for a future immune to…
-
Brain Cancer Awareness Month: 2022 Immunotherapy Research Updates
This Brain Cancer Awareness Month, discover new research, new treatments, and progress for a future immune to…
-
Melanoma Monday: 2022 Immunotherapy Research Updates
This Melanoma Monday, discover new research, new treatments, and progress for a future immune to melanoma.
-
Head and Neck Cancer Awareness Month: 2022 Immunotherapy Research Updates
This April for Head and Neck Cancer Awareness Month, discover the new research, new treatments, and progress…
-
Esophageal Cancer Awareness Month: 2022 Immunotherapy Research Updates
This April for Esophageal Cancer Awareness Month, discover the new research, new treatments, and progress for a…
-
FDA Immunotherapy Approvals in 2022
As drug development in cancer immunotherapy has accelerated, the U.S. Food and Drug Administration has made several…
